GARDANI, GIANSTEFANO
GARDANI, GIANSTEFANO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors
2004 Lissoni, P; Brivio, F; Fumagalli, L; Messina, G; Ghezzi, V; Frontini, L; Giani, L; Vaghi, M; Ardizzoia, A; Gardani, G
Endocrine effects of erythropoietin in cancer patients
2004 Lissoni, P; Perego, M; Veronese, E; Fumagalli, G; Brivio, F; Colciago, M; Messina, G; Rovelli, F; Brivio, R; Gardani, G
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia
2004 Lissoni, P; Vaghi, M; Pescia, S; Rovelli, F; Ardizzola, A; Valtulina, F; Malugani, F; Gardani, G; Tancini, G
Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer
2004 Frontini, L; Lissoni, P; Vaghi, M; Perego, M; Pescia, S; Ardizzoia, A; Gardani, G
Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms
2005 Lissoni, P; Meregalli, S; Bonetto, E; Mancuso, M; Brivio, F; Colciago, M; Gardani, G
The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results
2005 Bignami, A; Lissoni, P; Brivio, F; Galbiati, F; Pescia, S; Messina, G; Frontini, L; Meregalli, S; Gardani, G
Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer
2005 Lissoni, P; Bignami, A; Frontini, L; Manganini, V; Dapretto, E; Gardani, G; Viganò, P; Strada, G
Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients
2006 Gardani, G; Cerrone, R; Biella, C; Mancini, L; Proserpio, E; Casiraghi, M; Travisi, O; Meregalli, M; Trabattoni, P; Colombo, L; Giani, L; Vaghi, M; Lissoni, P
A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach
2007 Gardani, G; Cerrone, R; Biella, C; Galbiati, G; Proserpio, E; Casiraghi, M; Arnoffi, J; Meregalli, M; Trabattoni, P; Dapretto, E; Giani, L; Messina, G; Lissoni, P
Quality indicators in radiotherapy
2007 Cionini, L; Gardani, G; Gabriele, P; Magri, S; Morosini, P; Rosi, A; Viti, V
Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test.
2007 Messina, G; Lissoni, P; Bartolacelli, E; Fumagalli, L; Brivio, F; Colombo, E; Gardani, G
A case-control study of Panicum Miliaceum in the treatment of cancer chemotherapy-induced alopecia
2007 Gardani, G; Cerrone, R; Biella, C; Galbiati, B; Proserpio, E; Casiraghi, M; Travisi, O; Meregalli, M; Trabattoni, P; Colombo, L; Giani, L; Messina, G; Arnoffi, J; Lissoni, P
Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer
2007 Ardizzoia, A; Colombo, I; Giordano, M; Aglione, S; Isa, L; Scanni, A; Scognamiglio, G; Bertolini, A; Villa, F; Gardani, G
Efficacy of HT 7 point acupressure stimulation in the treatment of insomnia in cancer patients and in patients suffering from disorders other than cancer
2008 Cerrone, R; Giani, L; Galbiati, B; Messina, G; Casiraghi, M; Proserpio, E; Meregalli, M; Trabattoni, P; Lissoni, P; Gardani, G
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastases.
2008 Lissoni, P; Meregalli, S; Curreri, S; Messina, G; Brivio, F; Fumagalli, L; Colciago, M; Gardani, G
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC)
2008 Ardizzoia, A; Arnoffi, J; Colombo, I; Villa, F; Dapretto, E; Frontini, L; Lissoni, P; Vaghi, M; Cazzaniga, M; Vigano, I; Gardani, G; Bidoli, P
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)]
2008 Ardizzoia, A; Arnoffi, J; Colombo, I; Villa, F; Dapretto, E; Frontini, L; Lissoni, P; Vaghi, M; Cazzaniga, M; Vigano, I; Gardani, G; Bidoli, P
Quality assurance of 3D-CRT: indications and difficulties in their applications.
2009 Begnozzi, L; Benassi, M; Bertanelli, M; Bonini, A; Cionini, L; Conte, L; Fiorino, C; Gabriele, P; Gardani, G; Giani, A; Magri, S; Morelli, M; Morrica, B; Olmi, P; Orecchia, R; Penduzzu, G; Raffaele, L; Rosi, A; Tabocchini, M; Valdagni, R; Viti, V
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.
2009 Paccagnella, A; Ghi, M; Loreggian, L; Buffoli, A; Koussis, H; Mione, C; Bonetti, A; Campostrini, F; Gardani, G; Ardizzoia, A; Dondi, D; Guaraldi, M; Cavallo, R; Tomio, L; Gava, A
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer
2011 Guerra, L; Niespolo, R; DI PISA, G; Ippolito, D; De Ponti, E; Terrevazzi, S; Bovo, G; Sironi, S; Gardani, G; Messa, M